Click on a point to find the contact information for regional representatives

Born from two national collaborative projects.

01 The national survey project

The national survey project

A national benchmark of French perioperative practices in liver transplantation revealing significant variations due to the lack of scientific data and unmet needs.

Read about the project
2 years project duration
2025 published
02 HEMOTRANSPLANT Study

HEMOTRANSPLANT Study

HEMOTRANSPLANT is a nationwide multicenter study of 1,200 liver transplant patients designed to identify predictors of transfusion needs, enabling improved hemorrhage management, reduced costs, and standardized clinical practice.

Read about the project
2 years project duration
Q3 2026 last patient enrolled
€412K funds raised
SFAR & LFB sponsors

Now building together

The French liver
transplantation database project

with  Pre operative  Data

Strong Data.

01 Cardiovascular & Hemodynamics
  • Q01 Preoperative cardiovascular assessment
  • Q02 Incidence and outcomes of cardiovascular complications
  • Q03 Perioperative hemodynamic optimization: vasopressors, fluids & monitoring
02 Hemostasis & Transfusion
  • Q01 Hemostasis point-of-care testing
  • Q02 Hemostatic therapies: which ones, when, and for whom?
  • Q03 Blood cell salvage strategies
  • Q04 Bleeding vs thrombosis balance
03 Immunity, Immunosuppression & Infectious Diseases
  • Q01 Personalized infection prevention: vaccination, viral, fungal, and bacterial prophylaxis strategies
  • Q02 Tailored immunosuppressive strategies
  • Q03 Immune monitoring
  • Q04 Facing multidrug-resistant organisms
04 Acute Liver Failure & ACLF
  • Q01 Incidence and perioperative outcomes of ALF and ACLF
  • Q02 Therapeutic plasma exchange as a bridge to transplant
  • Q03 Innovative immunomodulatory pharmaceutical and extracorporeal strategies
  • Q04 Predictors of transplant futility
05 Nephrology
  • Q01 Liver-kidney crosstalk before, during, and after LT
  • Q02 Assessing the impact of intraoperative kidney replacement therapy in patients with preoperative AKI
  • Q03 Minimizing kidney toxicity of immunosuppressive therapy
  • Q04 Long-term kidney outcomes after liver transplantation
06 Nutrition, Rehabilitation & Quality of Life
  • Q01 Prehabilitation in liver transplantation candidates
  • Q02 Fast track pathways after the surgery
  • Q03 Patient-reported outcome measures and patient-reported experience measures
  • Q04 Quality of life and associated risk factors
  • Q05 Post-intensive care syndrome and post-traumatic stress disorders: incidence and outcomes
07 Oncology
  • Q01 Impact of immunotherapy and new locoregional therapies on perioperative outcomes of patients with HCC
  • Q02 New indications of LT for primary and secondary cancer: window of opportunity and long-term outcomes
  • Q03 Perioperative immunosuppressive strategies: balancing graft rejection vs oncological recurrence
08 Graft Allocation & Function
  • Q01 Predictive tools and machine-learning algorithms to anticipate graft function
  • Q02 Donor-recipient matching
  • Q03 Large-scale assessment of machine perfusion impact
Powered by
Institutions
Powered by
Patients
Transhépate
Powered by
You?

Want to support the project ?  Contact us  and join the adventure.

Paris skyline
BiLiver